Literature DB >> 14421930

[On visual disturbances and eye changes in quinoline therapy of primary chronic articular rheumatism].

R MARX, P BRECH, T MEISNER.   

Abstract

Entities:  

Keywords:  EYE/pharmacology; QUINOLINES/toxicology

Mesh:

Substances:

Year:  1960        PMID: 14421930     DOI: 10.1007/bf02341627

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  7 in total

1.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

2.  The ocular complications of chloroquine therapy.

Authors:  H E HOBBS; C D CALNAN
Journal:  Lancet       Date:  1958-06-07       Impact factor: 79.321

3.  Treatment of lupus erythematosus with mepacrine.

Authors:  F PAGE
Journal:  Lancet       Date:  1951-10-27       Impact factor: 79.321

4.  Edema of the corneal epithelium caused by atabrine; observation on three patients.

Authors:  F M REESE
Journal:  Bull Johns Hopkins Hosp       Date:  1946-06

5.  STUDIES ON THE CHRONIC TOXICITY OF CHLOROQUINE (SN-7618).

Authors:  A S Alving; L Eichelberger; B Craige; R Jones; C M Whorton; T N Pullman
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

6.  Edema of cornea precipitated by quinacrine (atabrine).

Authors:  W P CHAMBERLAIN; D J BOLES
Journal:  Arch Ophthal       Date:  1946-02

7.  Unusual toxic manifestations to amodiaquin (camoquin).

Authors:  D C BLEIL
Journal:  AMA Arch Derm       Date:  1958-01
  7 in total
  1 in total

1.  [Changes in the human electro-retinogram during long-term resochin therapy].

Authors:  B SCHMIDT; W MUELLER-LIMMROTH; G HEINMUELLER; W BOEKE; A BAEUMER
Journal:  Klin Wochenschr       Date:  1961-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.